#JAMAOnc
LightNews LightNews
stoverlab.bsky.social
Study in #JAMAOnc from Scotland/Wales of nearly 50k #breastcancer patients suggests vaginal estrogen use *NOT* associated w increase risk of breast cancer-specific mortality.

More reassuring data 👍

jamanetwork.com/journals/jam...
Vaginal Estrogen Therapy Use and Survival in Breast Cancer
This cohort study compares the mortality risk associated with vaginal estrogen therapy vs no hormone replacement therapy in 2 cohorts of patients with breast cancer in Scotland and Wales.
jamanetwork.com
November 23, 2024 at 2:28 PM
mtmdphd.bsky.social
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19 [Nov 3, 2022] @ZiadBakouny et al. @DrChoueiri @TMWiseDraper @COVID19nCCC @JAMAOnc jamanetwork.com/journals/jam... #COVID19nCancer #CCC19 #IDonc #ImmunoOnc #NCT04354701
November 18, 2024 at 5:31 PM
apccc.bsky.social
How Can Guidelines Give Clearer Guidance on #ProstateCancer Screening? Viewpoint out on @JAMAOnc

Highlights need for unified framework to produce clear & consistent screen guidelines

jamanetwork.com/journals/jam...

@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
How Can Guidelines Give Clearer Guidance on Prostate Cancer Screening?
This Viewpoint explores how guideline groups can come together to agree on a framework that produces clear and unified recommendations.
jamanetwork.com
November 28, 2024 at 3:18 PM
oncoalert.bsky.social
The OncoAlert🚨 #SABCS24 DAY 3 Newsletter
Out tomorrow morning 7am (San Antonio, Tx)

REGISTER AT www.OncoAlert360.com OR https://buff.ly/48Xpgz0

✅INSEMA ( @NEJM )
✅EUROPA (@TheLancetOncol )🇪🇺
✅COMET (@JAMAOnc )☄️
✅SUPREMO⚖️
✅PATINA
✅SOUND🔊
✅P-Veriry
December 13, 2024 at 12:31 AM
mtmdphd.bsky.social
Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc ow.ly/SJJu50FcCmD #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc
Survival in Patients With Hematologic Cancers and COVID-19
This cohort study evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic cancers and COVID-19.
ow.ly
November 18, 2024 at 1:10 AM
mtmdphd.bsky.social
Disease-Specific Hashtags [CTO] for Online Communication About Cancer Care [11/5/15] @subatomicdoc @audvin @pfanderson @mtmdphd @DrAttai Johnston, @drdonsdizon @JAMAOnc ow.ly/UiZ81
November 18, 2024 at 3:56 AM
mtmdphd.bsky.social
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19 [Nov 3, 2022] @ZiadBakouny et al. @DrChoueiri @TMWiseDraper @COVID19nCCC @JAMAOnc jamanetwork.com/journals/jam... #COVID19nCancer #CCC19 #IDonc #ImmunoOnc #NCT04354701
March 10, 2025 at 5:49 PM
halletjulie.bsky.social
My🔝10📝of2⃣0⃣2⃣4⃣(cont'd)

Guidance on biomarkers🧬 for #NETs🦓 @JAMAOnc by @nanets.bsky.
▪️Few are treatment-informing
▫️Most need further research, including NGS, TMB, NETPET score

Which markers do #NETologists currently use?🤔

jamanetwork.com/journals/jam...

#OncSky #MedSky #NETSKy #SurgSky #PBsky
December 15, 2024 at 1:05 PM
arndtvogel.bsky.social
First-Line Systemic Treatment for Initially Unresectable
CRC Liver Metastasis
🔎Post Hoc CAIRO5
@JAMAOnc
doi.org/10.1001/jama...
👉FOLFOX or FOLFIRI plus Bev seems to be an option for all pts
👉Excellent OS for pts with early recurrence & salvage local Tx
@myESMO
November 25, 2024 at 9:53 AM
syedaahmad5.bsky.social
Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma: The NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical Trial ⁦‪@JAMAOnc‬⁩

jamanetwork.com/journals/jam...
Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma
This phase 3 randomized clinical trial evaluates whether stereotactic body radiation therapy improves outcomes in patients with locally advanced hepatocellular carcinoma compared with sorafenib alone.
jamanetwork.com
December 20, 2024 at 11:12 PM
syedaahmad5.bsky.social
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX ⁦‪@JAMAOnc‬⁩ ⁦‪@MarcBesselink‬⁩

jamanetwork.com/journals/jam...
Adjuvant Chemotherapy After Resection of Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX
This cohort study investigates the association of adjuvant chemotherapy following resection of pancreatic adenocarcinoma after preoperative FOLFIRINOX in full or modified dosing with overall survival,...
jamanetwork.com
April 16, 2025 at 11:43 AM
icosociety.bsky.social
Today in @JAMAOnc, we stressed the importance of interdisciplinary collaboration as the best way to mitigate effects and protect the #hearts of #cancer patients.

Read the positioning statement: jamanetwork.com/journals/jam...
Immune Checkpoint Inhibitor–Associated Cardiovascular Toxic Effects
This Special Communication outlines the International Cardio-Oncology Society position on immune checkpoint inhibitor–associated cardiovascular toxic effects.
jamanetwork.com
November 13, 2025 at 10:12 PM
themis2023.bsky.social
Pas nouveau, ça fait un moment en réalité.

Il s'est opposé à la surveillance des eaux usées (2023), RT Vinay Prasad (comme Docdu16), l'un des pires désinformateurs sur le Covid, et a quand même lâché qu'après tout les gens mouraient de maladies depuis longtemps...
1/2
Damien BARRAUD MD @fluidloading. "Je t'emmerde Bisous" C-A GUSTAVE @C_A_Gustave. 1/24 "Tant parmi les libertariens "primaires" que chez certains médecins se prétendant les "chevaliers blancs" de la bonne science, je vois monter un discours qui me laisse plus que dubitatif. Ils s'opposent à la surveillance des eaux usées et à la gestion de la qualité de l'air" Damien BARRAUD MD @fluidloading Poke @docdu16 Vinay Prasad MD MPH @VPrasadMDMPH. Jun 20 JUST OUT in @JAMAOnc We look at all Adjuvant & Neoadjuvant drugs approved by FDA in last 5 years 43% of the time trials DON'T SAY what control arm pts get at relapse 75% of the time it is SUBOPTIMAL This means OS is "UNRELIABLE*... Tweet de Damien Barraud, 1er août 2023, au sujet de la surveillance des eaux usées : "Aucun intérêt à partir colorier de jolies cartes Merci d'arrêter avec ce truc là"
November 2, 2025 at 2:00 PM
mtmdphd.bsky.social
Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc ow.ly/SJJu50FcCmD #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc
February 3, 2025 at 12:28 AM
jlevinscherz.bsky.social
Today in #Employer Coverage: Those diagnosed with #cancer during the pandemic had higher mortality than expected
@JAMAOnc

open.substack.com/pub/employer...
Those diagnosed with cancer during the pandemic had higher mortality than expected
February 10, 2025
open.substack.com
February 10, 2026 at 10:46 AM
yalecancer.bsky.social
Congratulations to Dr. Sajid Khan, who has been appointed to the editorial board of the Journal of American Medical Association @jama.com Oncology #JAMAonc, one of the highest-ranked oncology journals in the world.
@yaleschoolofmed.bsky.social
May 16, 2025 at 2:07 PM
yabdoumd.bsky.social
Genomic assays have transformed BC care but they’re not the full story.
Our review @JAMAOnc shows that racial gaps in outcomes persist, even after accounting for molecular features —urging a more holistic approach to precision medicine.
@unclineberger.bsky.social

jamanetwork.com/journals/jam...
April 6, 2025 at 3:17 PM
fredhutch.org
New @JAMAOnc study links ultraprocessed foods to colorectal polyps in under-50s. But classifying foods was tricky, notes Fred Hutch's Dr. Marian Neuhouser, making results less certain. Still, findings echo recent research. Read more: https://nyti.ms/3M1ZfXL
Ultraprocessed Foods Linked to Colorectal Cancer Risk in Women Under 50
The study's findings track with recent research on the alarming rise of the cancer in younger adults.
nyti.ms
November 14, 2025 at 10:26 PM
fredhutch.org
New @JAMAOnc study links ultraprocessed foods to colorectal polyps in under-50s. But classifying foods was tricky, notes Fred Hutch's Dr. Marian Neuhouser, making results less certain. Still, findings echo recent research. Read more: https://nyti.ms/3M1ZfXL
Ultraprocessed Foods Linked to Colorectal Cancer Risk in Women Under 50
The study's findings track with recent research on the alarming rise of the cancer in younger adults.
nyti.ms
November 20, 2025 at 2:37 PM
oncoalert.bsky.social
The OncoAlert🚨 #SABCS24 DAY 3 RoundUp
REGISTER AT https://buff.ly/4eIDeWG OR https://buff.ly/48Xpgz0

✅INSEMA ( @NEJM )
✅EUROPA ( @TheLancetOncol )🇪🇺
✅COMET ( @JAMAOnc )☄️
✅SUPREMO⚖️
✅PATINA
and more
Day Three Video Round Up of The San Antonio Breast Cancer Symposium 2024
The OncoAlert🚨 #SABCS24 DAY 3 RoundUp REGISTER AT http://OncoAlert360.com OR https://buff.ly/48Xpgz0 ✅INSEMA ✅EUROPA ✅COMET ✅SUPREMO⚖️✅PATINAand more
youtu.be
December 13, 2024 at 5:28 PM
apccc.bsky.social
Long-Term Adverse Effects and Complications After Prostate Cancer Treatment out on
@JAMAOnc

jamanetwork.com/journals/jam...

These findings emphasize the need for thorough patient counseling on the potential risks of PCA treatment and highlight opportunities for cancer prevention strategies.
Long-Term Adverse Effects and Complications After Prostate Cancer Treatment
This cohort study assesses the long-term adverse effects and complications of prostate cancer treatment in treated patients compared with a general population of older males.
jamanetwork.com
December 19, 2024 at 7:00 PM
hofstrakidney.bsky.social
Blast from past @sfishbane @kdjhaveri @JAMAOnc Nephrotoxicity of the BRAF Inhibitors Vemurafenib and Dabrafenib http://ja.ma/2rntj25
December 9, 2024 at 8:26 PM
mtmdphd.bsky.social
Drivers of Clinical Trial Participation -- Demographics, Disparities, and Eligibility Criteria [Jan 10, 2019] Mishkin, Arnaldez, Ivy @JAMAOnc ow.ly/okeU30o3vAc #ClinicalTrials @SWOG #SWOGonc
Drivers of Clinical Trial Participation—Demographics, Disparities, and Eligibility Criteria
In the current issue of JAMA Oncology, Unger et al1 provide an overview from SWOG in response to the recommendations to modernize eligibility criteria for clinical trials developed by the American Soc...
ow.ly
April 9, 2025 at 2:53 PM
mtmdphd.bsky.social
Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation [Jan 10, 2019] @DrJoeUnger et al. @JAMAOnc ow.ly/Atg730o3v1F #ClinicalTrials @SWOG #SWOGonc
Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation
This national survey study of patients with cancer evaluates the association between patient comorbid conditions and cancer clinical trial participation.
ow.ly
April 9, 2025 at 2:53 PM
mtmdphd.bsky.social
COVID-19 and cancer: A review of the registry-based pandemic response [Sep 2, 2021] @ADesaiMD @DrTJM_MD et al. @JAMAOnc ow.ly/8fyz50G38Y4 #COVID19nCancer #CCC19 @COVID19nCCC
March 10, 2025 at 5:49 PM